title: Pacritinib Bests Available Therapies for Myelofibrosis.
mesh_terms: D001792:Blood Platelets / Q000187:drug effects; D001952:Bridged-Ring Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D053612:Janus Kinases / Q000037:antagonists & inhibitors; D055728:Primary Myelofibrosis / Q000188:drug therapy* / Q000473:pathology; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use*; D013154:Spleen / Q000187:drug effects
chemical_list: C561234:11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene; D001952:Bridged-Ring Compounds; D011743:Pyrimidines; D053612:Janus Kinases